Aduro Biotech

$14.60

$0.00 (0.00%) Today

$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch Aduro Biotech and buy or sell other stocks, options, and ETFs commission-free!

About ADRO

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes.

CEO

Stephen T. Isaacs

CEOStephen T. Isaacs

Employees

Employees96

Headquarters

Berkeley, California

HeadquartersBerkeley, California

Founded

2008

Founded2008

Employees

Employees96

ADRO Key Statistics

Market cap

1.18B

Market cap1.18B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

435.83K

Average volume435.83K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$4.04

52 Week high$4.04

52 Week low

$0.9011

52 Week low$0.9011

ADRO Earnings

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Estimated— per share

Actual

Expected Mar 8, After Hours

ActualExpected Mar 8, After Hours